202 related articles for article (PubMed ID: 28726783)
1. KMT2A promotes melanoma cell growth by targeting hTERT signaling pathway.
Zhang C; Song C; Liu T; Tang R; Chen M; Gao F; Xiao B; Qin G; Shi F; Li W; Li Y; Fu X; Shi D; Xiao X; Kang L; Huang W; Wu X; Tang B; Deng W
Cell Death Dis; 2017 Jul; 8(7):e2940. PubMed ID: 28726783
[TBL] [Abstract][Full Text] [Related]
2. KMT2A regulates cervical cancer cell growth through targeting VDAC1.
Zhang C; Hua Y; Qiu H; Liu T; Long Q; Liao W; Qiu J; Wang N; Chen M; Shi D; Yan Y; Xie C; Deng W; Li T; Li Y
Aging (Albany NY); 2020 May; 12(10):9604-9620. PubMed ID: 32436862
[TBL] [Abstract][Full Text] [Related]
3. RBFOX3 Promotes Tumor Growth and Progression via hTERT Signaling and Predicts a Poor Prognosis in Hepatocellular Carcinoma.
Liu T; Li W; Lu W; Chen M; Luo M; Zhang C; Li Y; Qin G; Shi D; Xiao B; Qiu H; Yu W; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Theranostics; 2017; 7(12):3138-3154. PubMed ID: 28839469
[TBL] [Abstract][Full Text] [Related]
4. RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression.
Liu YB; Mei Y; Long J; Zhang Y; Hu DL; Zhou HH
J Exp Clin Cancer Res; 2018 Aug; 37(1):182. PubMed ID: 30075819
[TBL] [Abstract][Full Text] [Related]
5. KMT2A and KMT2B Mediate Memory Function by Affecting Distinct Genomic Regions.
Kerimoglu C; Sakib MS; Jain G; Benito E; Burkhardt S; Capece V; Kaurani L; Halder R; Agís-Balboa RC; Stilling R; Urbanke H; Kranz A; Stewart AF; Fischer A
Cell Rep; 2017 Jul; 20(3):538-548. PubMed ID: 28723559
[TBL] [Abstract][Full Text] [Related]
6. Melatonin inhibits MLL-rearranged leukemia via RBFOX3/hTERT and NF-κB/COX-2 signaling pathways.
Tang YL; Sun X; Huang LB; Liu XJ; Qin G; Wang LN; Zhang XL; Ke ZY; Luo JS; Liang C; Peng CJ; Tang WY; Li Y; Huang W; Luo XQ; Deng W
Cancer Lett; 2019 Feb; 443():167-178. PubMed ID: 30550850
[TBL] [Abstract][Full Text] [Related]
7. NMI inhibits cancer stem cell traits by downregulating hTERT in breast cancer.
Feng X; Xu X; Xiao X; Zou K; Yu W; Wu J; Tang R; Gao Y; Hao J; Zhao X; Liao Y; Chen Y; Huang W; Guo W; Kang L; Deng W
Cell Death Dis; 2017 May; 8(5):e2783. PubMed ID: 28492540
[TBL] [Abstract][Full Text] [Related]
8. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W
Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422
[TBL] [Abstract][Full Text] [Related]
9. Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits.
Hao J; Fan W; Li Y; Tang R; Tian C; Yang Q; Zhu T; Diao C; Hu S; Chen M; Guo P; Long Q; Zhang C; Qin G; Yu W; Chen M; Li L; Qin L; Wang J; Zhang X; Ren Y; Zhou P; Zou L; Jiang K; Guo W; Deng W
J Exp Clin Cancer Res; 2019 Feb; 38(1):48. PubMed ID: 30717768
[TBL] [Abstract][Full Text] [Related]
10. KMT2A histone methyltransferase contributes to colorectal cancer development by promoting cathepsin Z transcriptional activation.
Fang Y; Zhang D; Hu T; Zhao H; Zhao X; Lou Z; He Y; Qin W; Xia J; Zhang X; Ye LC
Cancer Med; 2019 Jul; 8(7):3544-3552. PubMed ID: 31090199
[TBL] [Abstract][Full Text] [Related]
11. Establishment and characterization of a DOT1L inhibitor-sensitive human acute monocytic leukemia cell line YBT-5 with a novel KMT2A-MLLT3 fusion.
Wang Z; Shi Y; Liu H; Liang Z; Zhu Q; Wang L; Tang B; Miao S; Ma N; Cen X; Ren H; Dong Y
Hematol Oncol; 2019 Dec; 37(5):617-625. PubMed ID: 31701557
[TBL] [Abstract][Full Text] [Related]
12. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Chen R; Zhu J; Dong Y; He C; Hu X
Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
[TBL] [Abstract][Full Text] [Related]
13. Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth.
Zhang N; Zhang R; Zou K; Yu W; Guo W; Gao Y; Li J; Li M; Tai Y; Huang W; Song C; Deng W; Cui X
Cell Death Dis; 2017 Jul; 8(7):e2961. PubMed ID: 28749462
[TBL] [Abstract][Full Text] [Related]
14. Paediatric patients with acute leukaemia and KMT2A (MLL) rearrangement show a distinctive expression pattern of histone deacetylases.
Vega-García N; Malatesta R; Estella C; Pérez-Jaume S; Esperanza-Cebollada E; Torrebadell M; Català A; Gassiot S; Berrueco R; Ruiz-Llobet A; Alonso-Saladrigues A; Mesegué M; Pont-Martí S; Rives S; Camós M
Br J Haematol; 2018 Aug; 182(4):542-553. PubMed ID: 29978456
[TBL] [Abstract][Full Text] [Related]
15. Ret finger protein-like 3 promotes tumor cell growth by activating telomerase reverse transcriptase expression in human lung cancer cells.
Chen W; Lu J; Qin Y; Wang J; Tian Y; Shi D; Wang S; Xiao Y; Dai M; Liu L; Wei G; Wu T; Jin B; Xiao X; Kang TB; Huang W; Deng W
Oncotarget; 2014 Dec; 5(23):11909-23. PubMed ID: 25481043
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of MDR1, LRP, MRP, and topoisomerase IIalpha gene mRNA transcripts before and after interferon-alpha, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines.
Miracco C; Maellaro E; Pacenti L; Del Bello B; Valentini MA; Rubegni P; Pirtoli L; Volpi C; Santopietro R; Tosi P
Int J Oncol; 2003 Jul; 23(1):213-20. PubMed ID: 12792796
[TBL] [Abstract][Full Text] [Related]
17. MiR-661 inhibits glioma cell proliferation, migration and invasion by targeting hTERT.
Li Z; Liu YH; Diao HY; Ma J; Yao YL
Biochem Biophys Res Commun; 2015 Dec; 468(4):870-6. PubMed ID: 26585488
[TBL] [Abstract][Full Text] [Related]
18. A New Complex Karyotype Involving a KMT2A-r Variant Three-Way Translocation in a Rare Clinical Presentation of a Pediatric Patient with Acute Myeloid Leukemia.
Capela de Matos RR; Ney Garcia DR; Othman MAK; Moura Ferreira G; Melo JB; Carreira IM; Meyer C; Marschalek R; Costa ES; Land MGP; Liehr T; Ribeiro RC; Silva MLM
Cytogenet Genome Res; 2019; 157(4):213-219. PubMed ID: 30974445
[TBL] [Abstract][Full Text] [Related]
19. RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia.
Matthijssens F; Sharma ND; Nysus M; Nickl CK; Kang H; Perez DR; Lintermans B; Van Loocke W; Roels J; Peirs S; Demoen L; Pieters T; Reunes L; Lammens T; De Moerloose B; Van Nieuwerburgh F; Deforce DL; Cheung LC; Kotecha RS; Risseeuw MD; Van Calenbergh S; Takarada T; Yoneda Y; van Delft FW; Lock RB; Merkley SD; Chigaev A; Sklar LA; Mullighan CG; Loh ML; Winter SS; Hunger SP; Goossens S; Castillo EF; Ornatowski W; Van Vlierberghe P; Matlawska-Wasowska K
J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33555272
[TBL] [Abstract][Full Text] [Related]
20. KMT2A (MLL)-MLLT1 rearrangement in blastic plasmacytoid dendritic cell neoplasm.
Yang N; Huh J; Chung WS; Cho MS; Ryu KH; Chung HS
Cancer Genet; 2015 Sep; 208(9):464-7. PubMed ID: 26164398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
